Regeneron Pharmaceuticals, Inc. (BIT:1REGN)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	65,733	74,026	84,502	72,102	58,059	41,684
Market Cap Growth	-12.44%	-12.40%	17.20%	24.19%	39.28%	13.96%
Enterprise Value	52,033	58,974	72,751	62,474	50,391	39,063
Last Close Price	633.80	672.23	790.57	668.85	569.80	392.10
PE Ratio	16.85	17.37	23.63	17.76	8.18	14.51
PS Ratio	5.41	5.40	7.12	6.33	4.11	6.00
PB Ratio	2.49	2.61	3.60	3.40	3.52	4.63
P/TBV Ratio	2.61	2.72	3.75	3.54	3.52	4.63
P/FCF Ratio	18.27	20.91	24.10	17.42	10.11	25.45
P/OCF Ratio	15.21	17.34	20.33	15.37	9.32	19.48
EV/Sales Ratio	4.27	4.30	6.13	5.49	3.57	5.62
EV/EBITDA Ratio	13.88	13.19	17.28	12.51	6.18	12.25
EV/EBIT Ratio	15.92	14.73	19.00	13.37	6.37	13.04
EV/FCF Ratio	14.46	16.66	20.75	15.09	8.78	23.85
Debt / Equity Ratio	0.09	0.10	0.11	0.12	0.14	0.25
Debt / EBITDA Ratio	0.62	0.63	0.60	0.52	0.29	0.69
Debt / FCF Ratio	0.64	0.80	0.72	0.63	0.41	1.35
Asset Turnover	0.37	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.46	2.51	2.51	2.37	2.74	2.26
Quick Ratio	3.19	3.86	4.82	4.16	2.98	2.86
Current Ratio	4.06	4.73	5.69	5.06	3.56	3.63
Return on Equity (ROE)	15.19%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	6.16%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Invested Capital (ROIC)	13.50%	18.58%	22.38%	26.65%	60.13%	36.09%
Return on Capital Employed (ROCE)	10.70%	12.30%	14.30%	19.20%	41.80%	25.30%
Earnings Yield	5.94%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	5.47%	4.78%	4.15%	5.74%	9.89%	3.93%
Buyback Yield / Dilution	4.39%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.